Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Partanen

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
Computer Methods and Programs in Biomedicine|May 30, 2001
Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECTJ O Karonen, L Ostergaard, P Vainio, et al.
International Journal of Cancer|November 20, 2013
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus respondersO Hemminki, R Immonen, J Närväinen, et al.
Oncoimmunology|July 4, 2015
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8<sup>+</sup> T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancerL Vassilev, T Ranki, T Joensuu, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
Computer Methods and Programs in Biomedicine|May 30, 2001
Diffusion and perfusion MR imaging in acute ischemic stroke: a comparison to SPECTJ O Karonen, L Ostergaard, P Vainio, et al.
International Journal of Cancer|November 20, 2013
In vivo magnetic resonance imaging and spectroscopy identifies oncolytic adenovirus respondersO Hemminki, R Immonen, J Närväinen, et al.
Oncoimmunology|July 4, 2015
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8<sup>+</sup> T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancerL Vassilev, T Ranki, T Joensuu, et al.
Pageof 13